ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

35 hedge funds and large institutions have $2.74M invested in Oncternal Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 17 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

76% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 17

Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$73K
Puts
$18K
Net Calls
Net Calls Change

Top Buyers

1
+$282K
2
+$280K
3
+$41K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$10.5K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$9.24K

Top Sellers

1
-$381K
2
-$207K
3
-$102K
4
State Street
State Street
Massachusetts
-$87.7K
5
VF
Virtu Financial
New York
-$66K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2K
27
$2K
28
$1.43K
29
$1K
30
$1K
31
$1K
32
$1K
33
$1K
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
1
2